IBM’s AI may lead to new antimicrobials, drugs, and materials

PARIS, FRANCE - MAY 16: The logo of the software and computer services company IBM is displayed during the 4th edition of the Viva Technology show at Parc des Expositions Porte de Versailles on May 16, 2019 in Paris, France. Viva Technology, the new international event brings together 9000 startups with top investors, companies to grow businesses and all players in the digital transformation who shape the future of the internet. (Photo by Chesnot/Getty Images)


IBM says it’s developed a new AI system that can identify peptides with bacteria-fighting potental, drawing on existing research.Read More

Related Articles

This ‘AI doctor’ can assess skin melanoma as accurately as human dermatologists

Scientists from the University of Gothenburg have developed an algorithm that assesses the severity of skin melanoma as accurately as dermatologists. The system was developed to help doctors determine the stage that a skin cancer has reached. While patients often independently find melanomas by spotting a new mole or a change in an existing one, even dermatologists can struggle to decide whether it’s invasive or not. The researchers suspected that AI could assist them with the task. [Read: How Polestar is using blockchain to increase transparency] They classified the melanomas with a convolutional neural network (CNN), a powerful method of analyzing images that’s proven… This story continues at The Next Web

Scientists developed an AI system for predicting human psychosis

A team of European scientists led by researchers from the Max Planck institute recently developed the world’s first cybernetic system for predicting psychosis onset in high-risk patients. According to the NIH, about three percent of the general population (data is US-specific) will experience psychosis in their lifetimes. To put that in perspective, the odds you’ll be stung by a bee are approximately six million to one. Unfortunately, predicting psychosis in high-risk patients is a difficult task. The current paradigm requires intensive diagnosis by trained professionals at a specialized medical facility, something most of the world’s population lacks immediate access to.… This story continues at The Next Web

Here’s why we should never trust AI to identify our emotions

Imagine you are in a job interview. As you answer the recruiter’s questions, an artificial intelligence (AI) system scans your face, scoring you for nervousness, empathy and dependability. It may sound like science fiction, but these systems are increasingly used, often without people’s knowledge or consent. Emotion recognition technology (ERT) is in fact a burgeoning multi-billion-dollar industry that aims to use AI to detect emotions from facial expressions. Yet the science behind emotion recognition systems is controversial: there are biases built into the systems. [Read: Can AI read your emotions? Try it for yourself] Many companies use ERT to test customer…This story continues at The Next Web

Responses

Your email address will not be published. Required fields are marked *

Receive the latest news

Subscribe To Our Weekly Newsletter

Get notified about chronicles from TreatMyBrand directly in your inbox